Seth Klarman
Baupost Group
Baupost Group Portfolio 13F
Seth Klarman Holdings Activity
- Portfolio value:
- $12.33B≈ (-$233M≈)
- Previous value:
- $12.56B≈
- # of changes:
- 27
- New positions:
- 6
- Reported for:
- 30 Jun 2021 (Q2)
- Latest filing date:
- 13 Aug 2021
Baupost Group has disclosed a total of 27 changes to the portfolio in the (2021 Q2) SEC report(s): increased the number of shares of 4, bought 6 totally new, decreased the number of shares of 11 and completely sold out 6 position(s).
What stocks did Seth Klarman buy in 2021 Q2?
During 2021 Q2 Seth Klarman has bought 10 securities out of which top 5 purchases (by % change to portfolio) were (QRVO) Qorvo Inc (added shares +2.11%), (MU) Micron Technology Inc (added shares +32.08%), (META) Meta Platforms Inc (added shares +19.28%), (SJR) Shaw Communications Inc, CL-B (new buy) and (TBPH) THERAVANCE BIOPHARMA INC (added shares +13.45%).
27 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Garrett Motion Inc
|
new
|
+3,575,000
|
3,575,000
|
+0.23%
|
$7.98
|
+285.21%($30.74)
|
0.23%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
IRONSOURCE LTD-A
|
new
|
+8,000,000
|
8,000,000
|
+0.65%
|
$10.01
|
|
0.65%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
NOBLE CORP
|
new
|
+104,928
|
104,928
|
+0.02%
|
$23.64
|
+71.62%($40.58)
|
0.02%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
AURORA INNOVATION INC -CW28
|
new
|
+750,000
|
750,000
|
+0.01%
|
$1.80
|
-88.33%($0.21)
|
0.01%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
Aurora Innovation Inc
|
new
|
+6,000,000
|
6,000,000
|
+0.48%
|
$9.89
|
-32.91%($6.64)
|
0.48%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
Shaw Communications Inc, CL-B
|
new
|
+7,530,807
|
7,530,807
|
+1.77%
|
$28.96
|
|
1.77%
|
2021 Q2
|
≈ 0.25 years
|
|
|
|
Micron Technology Inc
|
+32.08%
|
+1,740,000
|
7,163,416
|
+1.2%
|
$84.98
|
+874.28%($827.94)
|
4.94%
|
2020 Q3
|
≈ 1.00 year
|
|
|
|
Meta Platforms Inc
|
+19.28%
|
+250,000
|
1,547,000
|
+0.71%
|
$347.71
|
+69.81%($590.44)
|
4.36%
|
2020 Q1
|
≈ 1.50 years
|
|
|
|
THERAVANCE BIOPHARMA INC
|
+13.45%
|
+1,175,000
|
9,910,168
|
+0.14%
|
$14.52
|
+16.15%($16.86)
|
1.17%
|
2014 Q2
|
≈ 7.25 years
|
|
|
|
Qorvo Inc
|
+2.11%
|
+110,000
|
5,334,466
|
+0.17%
|
$195.65
|
-54.65%($88.73)
|
8.47%
|
2017 Q1
|
≈ 4.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.